Objective-To investigate whether balloon dilatation of the aortic valve induces long-term macroscopic or histological changes or both to explain the restenosis process.
Abstract
Objective-To investigate whether balloon dilatation of the aortic valve induces long-term macroscopic or histological changes or both to explain the restenosis process.
Design-Prospective study of 39 consecutive patients. Sixteen later (mean (SD) 12 (10) months) required operation. This non-randomised subgroup was compared with 10 patients who had aortic valve replacement without prior dilatation.
Setting-University cardiology and cardiac surgery centre and pathology department.
Patients-16 patients who had aortic valve replacement because of failure of or restenosis after balloon dilatation of the aortic valve. Twelve resected valves were examined.
Interventions-Percutaneous balloon dilatation of the aortic valve (maximal balloon size: trefoil 3 x 12 mm balloon or bifoil 2 x 19 mm balloon) and surgical inspection before excision of the aortic valve leaflets during open-chest aortic valve replacement. Fixation, decalcification, and staining for histology.
Main outcome measures-Presence of long-term pathological changes in the resected valve and their relation to restenosis after balloon dilatation.
Results-Macroscopically the previously dilated valves were indistinguishable from valves from the patients who had valve replacement only. Microscopically, the dilated aortic valves showed areas of young scar tissue that Four patients died within 28 days after balloon dilatation. Two patients in severe heart failure died during the procedure after the first balloon inflation. In a third patient, also with severe failure, the procedure was successful but he died one week later of progressive heart failure. The fourth patient had signs of aortic base dissection after inflation of a bifoil 2 x 19 mm balloon and died 24 hours later. One patient was operated upon within one week of the procedure because of severe aortic regurgitation (table 2, case 7). The procedure was considered to be unsuccessful in four patients because the valve area had increased by less than 25% after dilatation. Two of these patients subsequently had surgery (table 2, cases 3 and 4). One was operated upon within one month, the other experienced some relief of symptoms and was operated upon 10 months later. Of the other two with failed procedures, one died 19 months after the procedure, while the last patient was in validity class II (New York Heart Association) six months after valve dilatation. Of the remaining 30 patients, 13 had surgery because of clinical restenosis. Table 2 shows the haemodynamic and clinical details of the patients who had surgery.
FOLLOW UP OF NON-SURGICAL PATIENTS
Eight patients died during follow up. Death occurred at a mean (SD) of 15 (5) , table 3 ). In this patient the valve was composed of a posteriorly situated thickened and heavily calcified cusp and of a less calcified anterior cusp (probably a fusion of the left and right coronary cusps). Balloon dilatation had lacerated (7 mm) the right side of the anterior cusp from the aortic wall. Because the posterior cusp was rigid, the radial balloon force was probably exerted more strongly on the more pliable cusp. Fracturing of calcific deposits was not grossly evident in any cases.
MICROSCOPIC EXAMINATION

Dilated valves
All the valves (table 4) showed the usual histological features of calcific aortic stenosis. '6 In two patients there was degenerative bone formation in the calcifications. In 1 1 of the 12 patients young scar tissue (consisting of a rather cell-rich pattern of fibroblasts, capillaries, and an inflammatory infiltrate composed of lymphocytes, plasma cells, and histiocytes) was present. This scar tissue seemed to fill up the small tears and lacerations in the dense collagenous tissue stroma (11 patients) ( fig IA) and the fractures in the calcified nodules (seven patients) (fig I B) . Fragments ofcalcium embedded in the young scar tissue were seen in 10 patients ( fig IC) . In one patient a commissure was re-sealed with recent scar tissue. Haemorrhages and fibrin within the valve stroma were seen in six patients, while superficial fibrin deposits and haemorrhages were seen in all patients. Histological examination showed superficial fibrin deposits, small haemorrhages, and ironloaden macrophages in the subendothelium of valves from the control group. Although lymphocytes, plasma cells, and capillaries were present in the looser connective tissue stroma surrounding the dense collagenous stroma in some patients, none of the control valves showed the areas of young scar tissue seen in the patients treated with balloon dilatation.
Discussion
Whatever the initial mechanism, the underlying pathology of calcific aortic stenosis in the elderly is severe fibrosis and considerable calcifications of the valve leaflets occasionally associated with commissural fusion. These pathological changes render the valve rigid and immobile."6
As evident from our study and other published reports""'2 17 the mechanisms of successful percutaneous balloon dilatation of the aortic valve are (a) cleavage or laceration of the dense collagenous valve stroma, (b) fracture and/or fragmentation of calcifications, and (c) separation of fused commissures. It seems that the final outcome of balloon dilatation mainly depends on the severity of the underlying pathological abnormalities in the valve and the extent of the injury created by the balloon. In the two patients who had insufficient dilatation procedures with an increase of the aortic valve area of less than 25% we did indeed see some injury to the valve leaflets, but apparently it was not extensive enough. Commeau et al reported a similar finding in an intraoperative study.9 They noticed that when the valve was extensively calcified there was no grossly obvious effect of dilatation. None the less, in one of our patients severe damage to the valve (a complete tear of a valve leaflet from the aortic wall) caused severe aortic regurgitation.
Injury to the aortic valve seems to be followed by scarring. We and others found that small tears or lacerations in the collagenous valve stroma, fractures in calcifications, and splits between commissures were filled up with young scar tissue. 2 17 Scar formation should be recognised as a possible mechanism for restenOSi2S13 Indeed, development, organisation, and collagenisation of the young scar tissue in the tears and fractures in the valve will ultimately restore the valve's immobility and lead to restenosis. In addition, it seems from our study that organisation and collagenisation of the scar tissue in these valves takes longer than in other tissues. We saw non-collagenous scar tissue in the valves 24 months after dilatation: normally a scar is completely organised and collagenised within six weeks. The lack of a direct vascular supply to the valve leaflets may explain this prolonged process of repair, which resembles the slowly progressive inflammatory restenosis can develop slowly so that some patients will have a relatively long-lasting complaint-free period. As a consequence, we think that on the basis of strict indications percutaneous balloon dilatation of the aortic valve still has a place in relieving aortic stenosis in elderly patients with inoperable severe aortic stenosis.
